Evidence map›Paper›PMID 30857174›Full record

ArticleInternational journal of molecular sciences2019

Urinary Metabolites Altered during the Third Trimester in Pregnancies Complicated by Gestational Diabetes Mellitus: Relationship with Potential Upcoming Metabolic Disorders.

Yamilé López-Hernández, Ana Sofía Herrera-Van Oostdam, Juan Carlos Toro-Ortiz, Jesús Adrián López, Mariana Salgado-Bustamante, Michael Murgu, Lourdes Mariela Torres-Torres

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Gestational age and models for predicting gestational diabetes mellitus.Metabolomics : Official journal of the Metabolomic Society · 2025
    Observational
  6. Article
  7. Article
  8. Article
  9. Risk Estimation of Gestational Diabetes Mellitus in the First Trimester.The Journal of clinical endocrinology and metabolism · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yamilé López-HernándezMetabolomics and Proteomics Laboratory, CONACyT-Universidad Autónoma de Zacatecas, 98066 Zacatecas, Mexico. ylopezher@conacyt.mx.ORCID 0000-0002-1068-603X
Ana Sofía Herrera-Van OostdamBiochemistry Department, Universidad Autónoma de San Luis Potosí, 7800 San Luis Potosí, Mexico. chromosomesxx.svo@gmail.com.
Juan Carlos Toro-OrtizGynecology and Obstetrics Division, Hospital Central "Dr. Ignacio Morones Prieto",7800 San Luis Potosí, Mexico. jcarlostoro@yahoo.com.mx.
Jesús Adrián LópezMicroRNAs Laboratory, Unidad Académica de Ciencias Biológicas, Universidad Autónoma de Zacatecas, 98066 Zacatecas, Mexico. jalopez@uaz.edu.mx.ORCID 0000-0001-8012-7041
Mariana Salgado-BustamanteBiochemistry Department, Universidad Autónoma de San Luis Potosí, 7800 San Luis Potosí, Mexico. mariana.salgado@uaslp.mx.ORCID 0000-0003-0242-7190
Michael MurguWaters Technologies of Brazil, 06400 Barueri, Brazil. michael_murgu@waters.com.
Lourdes Mariela Torres-TorresGynecology and Obstetrics Division, Hospital Central "Dr. Ignacio Morones Prieto",7800 San Luis Potosí, Mexico. mariela.torres161291@gmail.com.
Autonomous University of San Luis Potosí · MXHospital Central Dr. Ignacio Morones Prieto · MXUniversidad Autónoma de Zacatecas "Francisco García Salinas" · MXWaters (United States) · US

Funding

Consejo Nacional de Ciencia y Tecnología 290239 and 269795
6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a disorder in pregnancy with highest impact in the future life of both mother and newborn. Increasing incidence, economic impact, and potential for severe GDM-related pregnancy complications are some factors that have motivated the deep study of physiopathology, risk factors for developing GDM, and potential biomarkers for its diagnosis. In the present pilot study, we analyzed the urinary metabolome profile of GDM patients in the 3rd trimester of pregnancy, when GDM is already established and the patients are under dietary and pharmacological control. An untargeted metabolomics method based on liquid chromatography⁻mass spectrometry analysis was developed to identify differentially expressed metabolites in the GDM group. We identified 14 metabolites that are significantly upregulated in the urine of GDM patients, and, more importantly, we identified those related with the steroid hormone biosynthesis and tryptophan (TRP) metabolism pathways, which are associated with GDM pathophysiology. Thus, these metabolites could be screened as potential prognostic biomarkers of type two diabetes mellitus, coronary artery disease and chronic renal failure in future follow-up studies with GDM patients.

Indexed as

AdultChromatography, High Pressure LiquidDiabetes, GestationalFemaleHumansMass SpectrometryMetabolic Networks and PathwaysMetabolomicsPregnancyPregnancy Trimester, ThirdTryptophanTryptophangestational diabetes mellitusmass spectrometrymetabolomicstryptophanurine

Identifiers

PMID30857174
PMCPMC6429483
OpenAlexW2921391527

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.